Summary
Omicron Biochemicals Inc
Founded in 1982
Description
Omicron Biochemicals specializes in the synthesis of 13C, 2H, 15N and 18O labeled carbohydrates, nucleosides, and derivatives. They develop new and improved methods to introduce stable isotopes into biologically important compounds. Their strengths lie...
Strengths
- Omicron Biochemicals Inc has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
Weaknesses
- Since Omicron Biochemicals Inc was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
Omicron Biochemicals Inc's annual revenue
$1344000
Based on Kona Equity data
-
Revenue per employee
$192000
-
Variance of revenue growth
0.2
-
Annual revenue growth since founding
$32000
-
Revenue growth rate from first known quarter to current
-85.0%
Employee Count
7 employees
-
Employee growth rate from first known quarter to current
-85.7%
Executives
Paul Bondo
Manager
p**@omicronbio.comBrian Tang
IT Support Technician
b**@omicronbio.comLaura Cummins
Production Chemist
l**@omicronbio.comRobert Sproston
Contract Engineer
r**@omicronbio.comAnthony Serianni
Professor of Chemistry and Biochemistry
a**@omicronbio.comShikai Zhao
Senior Research Scientist
s**@omicronbio.comG Score - 5
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Omicron Biochemicals Inc
- Category: Pharmaceuticals
- Industry: Laboratory
- SIC: 283; 28
- NAICS: 3254; 32
See similar companies
-
By City South Bend Small Laboratory in South Bend Mid-size Laboratory in South Bend Pharmaceuticals in South Bend Small Pharmaceuticals in South Bend Mid-size Pharmaceuticals in South Bend
-
By State IN Small companies in IN Pharmaceuticals in IN Small Pharmaceuticals in IN Mid-size Pharmaceuticals in IN Small Laboratory in IN Mid-size Laboratory in IN
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Laboratory Small Laboratory Mid-size Laboratory Pharmaceuticals and Laboratory
-
Firmographic data G Score of 5 Founded in 1982 SIC: 283 SIC: 28 NAICS: 3254 NAICS: 32 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Omicron Biochemicals Inc's headquarters are located at 115 S HILL St. South Bend, IN 46617.
Omicron Biochemicals Inc's official website is omicronbio.com
Omicron Biochemicals Inc's annual revenue is $1.3 M.
Omicron Biochemicals Inc's SIC: 283; 28
Omicron Biochemicals Inc's NAICS: 3254; 32.
Omicron Biochemicals Inc has 7 employees
Omicron Biochemicals Inc is in the industry of Pharmaceuticals.